"10.1371_journal.pone.0100777","plos one","2014-06-24T00:00:00Z","Naoto Terami; Daisuke Ogawa; Hiromi Tachibana; Takashi Hatanaka; Jun Wada; Atsuko Nakatsuka; Jun Eguchi; Chikage Sato Horiguchi; Naoko Nishii; Hiroshi Yamada; Kohji Takei; Hirofumi Makino","Department of Medicine and Clinical Science, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan; Department of Diabetic Nephropathy, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan; Department of Neurochemistry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan","Conceived and designed the experiments: DO. Performed the experiments: NT DO HT TH CSH. Analyzed the data: JW AN JE NN HY. Wrote the paper: DO KT HM.","D. Ogawa belongs to the Department of Diabetic Nephropathy, which is endowed by Boehringer Ingelheim. J. Wada is a consultant for Boehringer Ingelheim and receives speaker honoraria from Novartis. H. Makino is a consultant for AbbVie, Astellas and Teijin, receives speaker honoraria from Astellas, Boehringer-ingelheim, Chugai, Daiichi Sankyo, Dainippon Sumitomo, Kyowa Hakko Kirin, MSD, Novartis, Pfizer, Takeda, and Tanabe Mitsubishi, and receives grant support from Astellas, Boehringer-ingelheim, Daiichi Sankyo, Dainippon Sumitomo, Kyowa Hakko Kirin, Mochida, MSD, Novartis, Novo Nordisk, Pfizer, Takeda, and Tanabe Mitsubishi. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2014","06","Naoto Terami","NT",12,TRUE,1,5,5,3,TRUE,FALSE,FALSE,0,NA,FALSE
